Texas Rheumatology Research Institute LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lupus (SLE)2 trials
• Sjögren's disease1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Aurinia Pharmaceuticals Inc.1 trial

Running trials

• Recruiting

  PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

  NCT07611214· Phase 4· Aurinia Pharmaceuticals Inc.· Source

• Recruiting

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Nipocalimab in Moderate to Severe Sjogren's Disease

  NCT06741969· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)2 recruiting